Celldex Therapeutics, Inc.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
Asset Breakdown FY2016
Total Assets: $383.4M
Liabilities Breakdown FY2016
Total Liabilities: $117.9M
Asset Breakdown
Total Assets: $383.4M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $42.5M | 11.1% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $13.2M | 3.4% |
| Goodwill | $91.0M | 23.7% |
| Intangible Assets | $81.5M | 21.3% |
| Other Assets | $155.2M | 40.5% |
Liabilities Breakdown
Total Liabilities: $117.9M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.7M | 1.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $116.2M | 98.5% |